Global economic burden of diabetes in adults: Projections from 2015 to 2030

Diabetes Care

Volumn 41, Issue 5, 2018, Pages 963-970

  Bommer, Christian ^a   Sagalova, Vera ^a   Heesemann, Esther ^a   Manne Goehler, Jennifer ^b,c   Atun, Rifat ^b,c   Bärnighausen, Till ^c,d,e   Davies, Justine ^f,g   Vollmer, Sebastian ^a,c  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e AFRICA HEALTH RESEARCH INSTITUTE   (South Africa)

^f KING'S COLLEGE LONDON   (United Kingdom)

^g UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT;

ADULT; AGED; AGING; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DIABETES MELLITUS; DISEASE BURDEN; DISEASE CONTROL; FEMALE; GLOBAL ECONOMIC BURDEN; GROSS NATIONAL PRODUCT; HEALTH CARE COST; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HEALTH ECONOMICS; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; PREDICTION; PREVALENCE; SOCIAL SECURITY; SUSTAINABLE GROWTH; TREND STUDY; URBANIZATION; WORLD HEALTH ORGANIZATION; YOUNG ADULT; COST; ECONOMICS; GLOBAL HEALTH; STATISTICS AND NUMERICAL DATA; TRENDS;

ADULT; AGED; COSTS AND COST ANALYSIS; DIABETES MELLITUS; FEMALE; GLOBAL HEALTH; HEALTH CARE COSTS; HUMANS; MALE; MIDDLE AGED; PREVALENCE; YOUNG ADULT;

EID: 85045767187     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc17-1962/-/DC1     Document Type: Article

References (37)

1. United Nations General Assembly. Resolution Adoptedbythe General Assemblyon 20 December 2006: World Diabetes Day. Resolution no. A/RES/61/225. 2007
2. United Nations General Assembly. Political Declaration of the High-Level Meeting of the General Assembly on the Prevention and Control of Non-Communicable Diseases. Resolution no. A/RES/66/2. 2012
3. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet 2016;387:1513-1530
4. GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016;388:1459-1544
5. World Health Organization. Global Action Plan for the Prevention and Control of Noncommunicable Diseases: 2013-2020 [Internet], 2013. Geneva, World Health Org. Available from http://www.who.int/nmh/events/ncd-action-plan/en/. Accessed 14 June 2017
6. United Nations General Assembly. Resolution Adopted by the General Assembly on 25 September 2015: Transforming Our World: The 2030 Agenda for Sustainable Development. Resolution no. A/RES/70/1. 2015
7. International Diabetes Federation. IDF Diabetes Atlas. 7th ed. [Internet], 2015. Brussels, Belgium, International Diabetes Federation. Available from http://www.diabetesatlas.org. Accessed 9 March 2016
8. Bommer C, Heesemann E, Sagalova V, et al. The global economic burden of diabetes in adults aged 20-79 years: a cost-of-illness study. Lancet Diabetes Endocrinol 2017;5:423-430
9. Bagust A, Hopkinson PK, Maslove L, Currie CJ. The projected health care burden of type 2 diabetes in the UK from 2000 to 2060. Diabet Med 2002;19(Suppl. 4):1-5
10. Huang ES, Basu A, O'Grady M, Capretta JC. Projecting the future diabetes population size and related costs for the U. S. Diabetes Care 2009;32:2225-2229
11. Vos T, Goss J, Begg S, Mann N. Projection of Health Care Expenditure by Disease: A Case Study From Australia. Brisbane, Australia, School of Population Health, University of Queensland, 2007
12. Waldeyer R, Brinks R, Rathmann W, Giani G, Icks A. Projection of the burden of type 2 diabetes mellitus in Germany: a demographic modelling approach to estimate the direct medical excess costs from 2010 to 2040. Diabet Med 2013;30:999-1008
13. Ogurtsova K, da Rocha Fernandes JD, Huang Y, et al. IDF Diabetes Atlas: global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract 2017;128:40-50
14. Zhang P, Zhang X, Brown J, et al. Global healthcare expenditure on diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010;87:293-301
15. Atun R, Davies JI, Gale E A M, et al. Diabetes in sub-Saharan Africa: from clinical care to health policy. Lancet Diabetes Endocrinol 2017;5:622-667
16. Hex N, Bartlett C, Wright D, Taylor M, Varley D. Estimating the current and future costs of type 1 and type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs. Diabet Med 2012;29:855-862
17. Javanbakht M, Mashayekhi A, Baradaran HR, Haghdoost A, Afshin A. Projection of diabetes population size and associated economic burden through 2030 in Iran: evidence from micro-simulation Markov model and Bayesian meta-analysis. PLoS One 2015;10:e0132505
18. Png ME, Yoong J, Phan TP, Wee HL. Current and future economic burden of diabetes among working-age adults in Asia: conservative estimates for Singapore from 2010-2050. BMC Public Health 2016;16:153
19. Rowley WR, Bezold C. Creating public awareness: state 2025 diabetes forecasts. Popul Health Manag 2012;15:194-200
20. Rowley WR, Bezold C, Arikan Y, Byrne E, Krohe S. Diabetes 2030: insights from yesterday, today, and future trends. Popul Health Manag 2017;20:6-12
21. Bloom DE, Chen S, Kuhn M, McGovern ME, Oxley L, Prettner K. The Economic Burden of Chronic Diseases: Estimates and Projections for China, Japan and South Korea. Cambridge, MA, National Bureau of Economic Research, 2017 (National Bureau of Economic Research Working Paper no. 23601)
22. Bloom DE, Cafiero ET, Jané-Llopis E, et al. The Global Economic Burden of Noncommunicable Diseases. Geneva, World Economic Forum, 2011
23. Stenberg K, Hanssen O, Edejer TT, et al. Financing transformative health systems towards achievement of the health Sustainable Development Goals: amodel for projected resource needs in 67 low-income and middle-income countries. Lancet Glob Health 2017;5:e875-e887
24. Global Burden of Disease Study 2015. Global Burden of Disease Study 2015 (GBD 2015) Results [Internet], 2016. Seattle, WA, Institute for Health Metrics and Evaluation. Available from http://ghdx.healthdata.org/gbd-results-tool. Accessed 14 May 2017
25. World Health Organization. Global Health Expenditure Database [Internet], 2015. Available from http://apps.who.int/nha/database/Select/Indicators/en. Accessed 1 October 2016
26. American Diabetes Association. Economic costs of diabetes in the U. S. in 2012. Diabetes Care 2013;36:1033-1046
27. Organisation for Economic Co-operation and Development. OECD. Stat [Internet], 2016. Available from http://stats.oecd.org/. Accessed14May 2017
28. The World Bank. World Development Indicators [Internet], 2016. Available from http://data.worldbank.org/data-catalog/world-developmentindicators. Accessed 4 July 2017
29. United Nations, Department of Economic and Social Affairs, Population Division. World Population Prospects: The 2015 Revision, DVD Edition, 2015
30. United Nations, Department of Economic and Social Affairs, Population Division. World Urbanization Prospects: The 2014 Revision, CD-ROM Edition [Internet], 2014. Available from https://esa.un.org/unpd/wup/CD-ROM/WUP2014-XLS-CD-FILES/WUP2014-F02-Proportion-Urban. xls. Accessed 9 March 2016
31. GBD 2015 SDG Collaborators. Measuring the health-related Sustainable Development Goals in 188 countries: a baseline analysis from the Global Burden of Disease Study 2015. Lancet 2016;388:1813-1850
32. Organisation for Economic Co-operation and Development. GDP long-term forecast [Internet], 2017. Available from https://data.oecd.org/gdp/gdp-long-term-forecast.htm. Accessed 14 May 2017
33. Dieleman JL, Campbell M, Chapin A, et al.; Global Burden of Disease Health Financing Collaborator Network. Future and potential spending on health 2015-40: development assistance for health, and government, prepaid private, and out-of-pocket health spending in 184 countries. Lancet 2017;389:2005-2030
34. Abdullah SM, Siddiqua S, Huque R. Is health care a necessary or luxury product for Asian countries? An answer using panel approach. Health Econ Rev 2017;7:4
35. Baltagi BH, Moscone F. Health care expenditure and income in the OECD reconsidered: evidence from panel data. In IZA Discussion Paper. Bonn, Germany, Institute for the Study of Labor, 2010, p. 4851
36. Chakroun M. Health care expenditure and GDP: aninternational panel smooth transition approach. In MPRA Paper. Munich, Germany, University Library of Munich, 2009, p. 17493
37. Dreger C, Reimers H-E. Health care expenditures in OECD countries: a panel unit root and cointegration analysis. In IZA Discussion Paper, Bonn, Germany, Institute for the Study of Labor, 2010, p. 1469